Ogorek Anthony Joseph’s Neogen NEOG Stock Holding History

Ogorek Anthony Joseph’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-880	Closed	-$13K	–	280
2024 Q2	$13K	Hold	880	–	–	﹤0.01%	191
2024 Q1	$13K	Hold	880	–	–	﹤0.01%	192
2023 Q4	$17K	Hold	880	–	–	0.01%	182
2023 Q3	$16K	Hold	880	–	–	0.01%	183
2023 Q2	$19K	Hold	880	–	–	0.01%	159
2023 Q1	$16K	Buy	+880	New	+$16.5K	0.01%	169

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Ogorek Anthony Joseph's NEOG Position: Q3 2024 in Review

Ogorek Anthony Joseph sold out of Neogen (NEOG) in Q3 2024, closing a stake of 880 shares — an estimated $13K sold.

Ogorek Anthony Joseph first reported a position in NEOG in Q1 2023 and held it in 6 quarters. The position peaked at $19K in Q2 2023. 337 funds tracked by Wall St. Rank hold NEOG as of Q3 2024.

Ogorek Anthony Joseph reported no remaining Neogen position as of Q3 2024 after selling out during the quarter.
Ogorek Anthony Joseph sold 880 Neogen shares in Q3 2024, an estimated $13K.
Ogorek Anthony Joseph first reported a position in Neogen in Q1 2023 and held it in 6 quarters.
Ogorek Anthony Joseph's Neogen position peaked at $19K in Q2 2023.
337 funds tracked by Wall St. Rank held Neogen as of Q3 2024.

Based on Ogorek Anthony Joseph's 13F filing for Q3 2024, filed 8 Nov 2024.